Susan Perry tells the story:
Patients Rising, [reporter Trudy Lieberman] reports, was founded by Jonathan Wilcox, a corporate communications and public relations consultant and adjunct professor at USC’s Annenberg School of Communications and his wife, Terry, a producer of oncology videos. . . .
Both Wilcox and his wife had worked with Vital Options International, another patient advocacy group with a special mission of generating global cancer conversations. She is a former executive director. A search of [Vital Options International’s] website showed that drug industry heavy hitters, such as Genentech, Eli Lilly, and Bristol-Myers Squibb, had in the past sponsored some of the group’s major activities . . .
Patients Rising is pushing back particularly strongly against Dr. Peter Bach, an epidemiologist at New York City’s Memorial Sloan Kettering Cancer Center, who has been outspoken about the high cost of cancer drugs.
Pretty horrible. Political advocacy is fine, and it could well be that there are good reasons for drug prices to remain high. But faking a patient advocacy organization, that’s not cool.
I will say, though, that artificial turf is a lot more pleasant than it used to be. 20 years ago, it felt like concrete; now it feels a lot more like grass. Except on really hot days when the turf feels like hot tar.
Full disclosure: I am working with colleagues at Novartis and getting paid for it.